Nutex Health Inc. (NASDAQ:NUTX) Sees Significant Increase in Short Interest

Nutex Health Inc. (NASDAQ:NUTX) saw a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 54,400 shares, a growth of 86.9% from the January 31st total of 29,100 shares. Approximately 1.7% of the company’s shares are short sold. Based on an average daily volume of 40,600 shares, the days-to-cover ratio is currently 1.3 days.

Nutex Health Trading Down 5.8 %

NASDAQ:NUTX opened at $51.69 on Tuesday. The firm has a market capitalization of $281.04 million, a price-to-earnings ratio of -5.51 and a beta of 0.20. Nutex Health has a 1-year low of $4.16 and a 1-year high of $69.45. The business’s 50-day moving average price is $44.89 and its two-hundred day moving average price is $32.56. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36.

Institutional Trading of Nutex Health

A number of hedge funds have recently modified their holdings of NUTX. Bank of America Corp DE increased its stake in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Beaird Harris Wealth Management LLC bought a new position in shares of Nutex Health during the third quarter worth $69,000. International Assets Investment Management LLC acquired a new position in shares of Nutex Health in the 3rd quarter valued at $188,000. Northern Trust Corp bought a new stake in shares of Nutex Health in the 4th quarter valued at $200,000. Finally, Baader Bank Aktiengesellschaft acquired a new stake in Nutex Health during the 4th quarter worth $206,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Benchmark boosted their price target on shares of Nutex Health from $45.00 to $60.00 and gave the stock a “buy” rating in a research note on Tuesday, November 12th. Maxim Group lifted their target price on shares of Nutex Health from $50.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, February 13th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.